Brown Brothers Harriman & Co’s AnaptysBio ANAB Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-766	Closed	-$21	–	1154
2021 Q3	$21	Hold	766	–	–	﹤0.01%	809
2021 Q2	$20	Hold	766	–	–	﹤0.01%	805
2021 Q1	$17	Hold	766	–	–	﹤0.01%	788
2020 Q4	$16K	Hold	766	–	–	﹤0.01%	805
2020 Q3	$11K	Hold	766	–	–	﹤0.01%	751
2020 Q2	$17K	Hold	766	–	–	﹤0.01%	703
2020 Q1	$11K	Hold	766	–	–	﹤0.01%	687
2019 Q4	$12K	Sell	766 -768	-50%	-$18.2K	﹤0.01%	864
2019 Q3	$54K	Hold	1,534	–	–	﹤0.01%	628
2019 Q2	$87K	Hold	1,534	–	–	﹤0.01%	506
2019 Q1	$112K	Hold	1,534	–	–	﹤0.01%	477
2018 Q4	$98K	Sell	1,534 -766	-33%	-$57K	﹤0.01%	443
2018 Q3	$229K	Hold	2,300	–	–	﹤0.01%	348
2018 Q2	$163K	Buy	+2,300	New	+$193K	﹤0.01%	361

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Brown Brothers Harriman & Co's ANAB Position: Q4 2021 in Review

Brown Brothers Harriman & Co sold out of AnaptysBio (ANAB) in Q4 2021, closing a stake of 766 shares — an estimated $21 sold.

Brown Brothers Harriman & Co first reported a position in ANAB in Q2 2018 and held it in 14 quarters. The position peaked at $229K in Q3 2018. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2021.

Brown Brothers Harriman & Co reported no remaining AnaptysBio position as of Q4 2021 after selling out during the quarter.
Brown Brothers Harriman & Co sold 766 AnaptysBio shares in Q4 2021, an estimated $21.
Brown Brothers Harriman & Co first reported a position in AnaptysBio in Q2 2018 and held it in 14 quarters.
Brown Brothers Harriman & Co's AnaptysBio position peaked at $229K in Q3 2018.
136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2021.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2021, filed 14 Feb 2022.